<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046159"><TermName>promyelocytic leukemia</TermName><TermPronunciation>(proh-MY-eh-loh-SIH-tik loo-KEE-mee-uh)</TermPronunciation><TermDefinition><DefinitionText>An aggressive (fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of chromosomes 15 and 17. Also called acute promyelocytic leukemia and APL.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000707762" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;promyelocytic leukemia&quot;" language="en" id="_3"/><MediaLink ref="CDR0000707763" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;leucemia promielocítica&quot;" language="es" id="_4"/><SpanishTermName>leucemia promielocítica</SpanishTermName><SpanishTermDefinition><DefinitionText>Tipo dinámico (de crecimiento rápido) de leucemia mieloide aguda en la que hay demasiadas células hematopoyéticas inmaduras en la sangre y la médula ósea. Por lo general, se caracteriza por un intercambio de partes entre los cromosomas 15 y 17. También se llama leucemia promielocítica aguda y LPA.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-09-18</DateLastModified></GlossaryTerm>
